Shares of medical device companies are trading lower amid sympathy with Intuitive Surgical after the company reported Q2 financial results and noted that the China market remains a challenge. Also, multiple analysts lowered their respective price targets on ISRG.

Intuitive Surgical's disappointing Q2 results and China market challenges are dragging down the broader medical device sector. Analyst downgrades further amplify the negative sentiment, suggesting potential headwinds for the industry.

This headline indicates a significant negative catalyst for the medical device sector. Intuitive Surgical's poor Q2 performance, particularly the challenges in the crucial China market, is causing 'sympathy selling' across the industry. Analyst downgrades on ISRG further validate the concerns, suggesting that the issues might not be isolated. Investors are likely re-evaluating growth prospects for the entire sector, especially those with significant international exposure. This could lead to continued downward pressure on medical device stocks and potentially present shorting opportunities or a 'wait and see' approach for long-term investors.